Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
posted on
Mar 26, 2020 06:19PM
Wouldn't that be a matter of looking back at the PI and PII trial at the dose response results. Whether they have the depth of detail on those trials as they do on the most recent trials would also be a limiting factor.
Heck is Cocco the monkey still alive from the last animal trial before PI started?
tada